FDA Inspection 1079952 — Atlanta Blood Services

Atlanta Blood Services — FEI 3001739811

The FDA completed an inspection of Atlanta Blood Services on Feb 6, 2019 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 6, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Atlanta, GA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.